Meddenovo Drug Design

Recent Finacing

Pre-Seed

Recent Raise

$1.1M

Meddenovo develops an AI molecular-modeling platform for designing and optimizing cyclic peptide therapeutics for cancer, autoimmune disorders and antimicrobial resistance, transitioning from services to SaaS and co-development with pharma.

Founded 2023

Rhone-Alpes, France

1-10

Private

meddenovo.com

Highlights

Focus Areas

Artificial Intelligence (AI)

Biopharma

Biotechnology

Health Care

Life Science

Pharmaceutical

Recent Investors

Financials

$1.1M

Total Raised

1

Funding round

1

Investor